Inhibition of platelet responses by N,N-diethyl-2[4-(phenoxymethyl)phenoxy]ethanamine, HCl (DPPE) occurs through multiple mechanisms.
Salmon
D M
DM
Department of Life Sciences, University of East London, Stratford, U.K.
D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002118:Calcium / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D015759:Ionomycin / Q000494:pharmacology; D007700:Kinetics; D010647:Phenyl Ethers / Q000494:pharmacology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D015290:Second Messenger Systems; D012701:Serotonin / Q000097:blood; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology
D010647:Phenyl Ethers; D010975:Platelet Aggregation Inhibitors; D012701:Serotonin; D015759:Ionomycin; D013917:Thrombin; C043062:tesmilifene; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium